37 results about "Recurrent disease" patented technology

The invention discloses an extcrnal antipruritic Chinese drug for curing the itch dermatoses, which is composed of 5 to 15 parts of shrubalthea bark, 15 to 30 parts of cnidium fruit, 5 to 10 parts of corktree bark, 5 to 10 parts of flavescent sophora root, 5 to 15 parts of root of paniculate swallowwort, 5 to 10 parts of dahurian angelica, 5 to 15 parts of Japanese ampelopsis, 5 to 10 parts of hyacinth bletilla, 15 to 30 parts of herb of Christina loosestrife, 10 to 15 parts of hairy vein agrimony, 10 to 15 parts of stemona Japonica Miq, 5 to 15 parts of capsule of weeping forsythia, 5 to 10 parts of common fenel, 15 to 30 parts of adsuki bean, 10 to 15 parts of knotweed and 10 to 15 parts of root-bark of densefruit ditany. The extcrnal Chinese drug for curing the itch dermatoses has the advantages of alleviating itch quickly, taking effect and curing fast, no scar at the skin damage position, convenient operation, no distress and toxic and side effects, etc. The patient can relieve itching in few seconds with the drug of the invention according to the clinical work, and can be cured without pains. The dermatoses of the acute disease can be cured in 1 to 3 days, and the chronic debilitated and recurrent disease can be cured in 1 to 3 monthes with matching with the Chinese drug for curing the itch dermatoses (internal and external application). The effective rate is 100 percent, the curative ratio is 100 percent, and the disease is not easy to be recurred after curing.

A detoxification plaster, comprising the composition and weight parts of raw materials of a traditional Chinese medicine composition: 12-22 parts of Cork, 10-16 parts of Sophora flavescens, 5-9 parts of whole scorpion, 3-10 parts of centipede, and 6-12 parts of borneol , 4 to 8 copies of rhubarb, and 15 to 25 copies of donkey-hide gelatin. It can obviously relieve the spasm and pain in the onset of swollen and painful emergencies such as carbuncle sore, eliminate the inflammatory reaction, and continue to take medicine for the repeated attacks of the swollen and painful real disease such as carbuncle sore. Promote the excretion of metabolites from the lesion. Promote wound angiogenesis, eliminate inflammation and edema, improve microcirculation, promote wound healing and granulation tissue generation. Also included are methods of preparation.

The invention relates to a diagnosis and treatment record management system and a diagnosis and treatment record management method. A diagnosis and treatment record management system includes a diagnosis and treatment information storage, a disease information storage, a compression unit and a decompression unit. The medical information storage stores one or more records in which patient identification information identifying the patient and details of medical treatment for the patient's disease are recorded. Recurrent disease recurs at relapse intervals, while recurrent disease recurs during relapse periods. The compressing unit compresses information recorded in a record in which medical treatment details for a recurring disease has been completed at least temporarily out of records stored in the medical treatment information memory. decompressed before at least one of a relapse interval and a relapse time period stored for the disease elapses from the baseline time of completion of treatment for the disease associated with the diagnosis details recorded in the record for which the recorded information has been compressed The unit decompresses the information compressed for the record.

The invention relates to an in situ hybridization detection kit of a RhoGDI2 (Rho GDP dissociation inhibitor beta) gene, a detection method and an application thereof. The kit comprises a hybridization probe, a label, a hybridization fluid and a potentiating agent, wherein, the hybridization probe sequence is shown in SEQ ID N0.1. The in situ hybridization detection method of the RhoGDI2 gene comprises the following steps that: a. the hybridization probe in the kit is contacted with the RNA to be detected in a zymolyte to form a hybridization complex; and b. the hybridization complex obtained in the step a is detected. The invention also relates to the application of the kit in the preparation of drugs for detecting the early cancer metastasis and recurrent diseases. The kit has the characteristics of high sensitivity and strong specificity. Meanwhile, the detection method has simple and convenient operation and can be used and popularized in the hospital over the district level.

The invention provides diagnostic markers of immunosenescence and methods of identifying individuals with impaired immune function based on the expression level of a combination of such markers in a biological sample obtained from said individual. Such combination of markers is useful for determining the susceptibility to nosocomial infections of an individual. Such combination of markers is also useful for predicting whether an individual will respond to active vaccination and become protected against recurring diseases.

USP14 is a biomarker for recurrent disease and inhibition of USP14 is of therapeutic benefit for women with endometrial or ovarian cancer.